Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDXS | Common Stock | Options Exercise | $70.4K | +35.7K | +4.56% | $1.97 | 820K | Mar 15, 2023 | Direct | F1 |
transaction | CDXS | Common Stock | Sale | -$146K | -35.7K | -4.36% | $4.09 | 784K | Mar 15, 2023 | Direct | F1, F2 |
transaction | CDXS | Common Stock | Options Exercise | $70.4K | +35.7K | +4.56% | $1.97 | 820K | Mar 16, 2023 | Direct | F1 |
transaction | CDXS | Common Stock | Sale | -$147K | -35.7K | -4.36% | $4.11 | 784K | Mar 16, 2023 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -35.7K | -12.5% | $0.00 | 250K | Mar 15, 2023 | Common Stock | 35.7K | $1.97 | Direct | F1 |
transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -35.7K | -14.29% | $0.00 | 214K | Mar 16, 2023 | Common Stock | 35.7K | $1.97 | Direct | F1 |
Id | Content |
---|---|
F1 | Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. |
F2 | This transaction was executed in multiple trades in prices ranging from $4.02 to $4.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F3 | This transaction was executed in multiple trades in prices ranging from $4.01 to $4.195, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |